Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1996 Dec;51(12):1178–1184. doi: 10.1136/thx.51.12.1178

Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.

D J Evans 1, P J Barnes 1, S M Spaethe 1, E L van Alstyne 1, M I Mitchell 1, B J O'Connor 1
PMCID: PMC472760  PMID: 8994512

Abstract

BACKGROUND: Leukotriene (LT) B4 is a potent neutrophil chemoattractant and also stimulates eosinophils in vitro, but its role in asthmatic inflammation is unknown. METHODS: The effect of the novel LTB4 receptor antagonist, LY293111, was examined using allergen challenge as a model for asthmatic inflammation in 12 atopic asthmatic subjects in a double blind placebo controlled crossover trial. Subjects with an established early (EAR) and late asthmatic response (LAR) to allergen at screening received oral LY293111 in a dose of 112 mg three times daily for seven days or placebo before further allergen challenge. Each treatment was separated by a washout period of 28 days. Individuals underwent histamine challenge one hour before and three hours after allergen challenge. Bronchoalveolar lavage (BAL) fluid was obtained at bronchoscopy 24 hours after allergen challenge. RESULTS: There was no difference in baseline lung function, EAR, LAR, or in airway responsiveness to histamine before and after allergen between placebo and LY293111. By contrast, treatment with LY293111 significantly reduced the number of neutrophils in BAL fluid expressed as both absolute cell numbers and percentage cell differential counts: absolute cell counts, median (range) 0.04 (0.02-0.15) x 10(6) after LY293111, 0.09 (0.02-0.43) x 10(6) after placebo; percentage differential cell counts 0.35 (0.1-2.0) after LY293111, 0.80 (0.1-3.6) after placebo (p < 0.05). Eosinophils, macrophages, and lymphocytes in BAL fluid did not differ between treatments. There was a significant reduction in the concentration of myeloperoxidase (MPO) with both placebo (16 (6.6) ng/ml) and LY293111 (3.5 (1.8) ng/ml) and of LTB4 (placebo 4.6 (1.2) pg/ml, LY293111 2.2 (0.2) pg/ml). Concentrations of LTC4 and interleukin 8 were reduced, although not significantly, whereas concentrations of interleukin 6, GM-CSF, and TNF-alpha were unchanged by LY293111. CONCLUSIONS: These results demonstrate an influence of LTB4 on neutrophil influx and activation in the airway following allergen challenge. Despite this anti-inflammatory effect, there was no measured physiological benefit and this questions the functional role of the neutrophil in the pathophysiology of allergen induced asthma.

Full text

PDF
1178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Chung K. F., Page C. P. Inflammatory mediators and asthma. Pharmacol Rev. 1988 Mar;40(1):49–84. [PubMed] [Google Scholar]
  2. Barnes P. J. Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 2):S42–S49. doi: 10.1164/ajrccm/150.5_Pt_2.S42. [DOI] [PubMed] [Google Scholar]
  3. Black P. N., Fuller R. W., Taylor G. W., Barnes P. J., Dollery C. T. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. Thorax. 1989 Jun;44(6):491–495. doi: 10.1136/thx.44.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broide D. H., Lotz M., Cuomo A. J., Coburn D. A., Federman E. C., Wasserman S. I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992 May;89(5):958–967. doi: 10.1016/0091-6749(92)90218-q. [DOI] [PubMed] [Google Scholar]
  5. Claesson H. E., Odlander B., Jakobsson P. J. Leukotriene B4 in the immune system. Int J Immunopharmacol. 1992 Apr;14(3):441–449. doi: 10.1016/0192-0561(92)90174-j. [DOI] [PubMed] [Google Scholar]
  6. De Monchy J. G., Kauffman H. F., Venge P., Koëter G. H., Jansen H. M., Sluiter H. J., De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985 Mar;131(3):373–376. doi: 10.1164/arrd.1985.131.3.373. [DOI] [PubMed] [Google Scholar]
  7. Durham S. R. Late asthmatic responses. Respir Med. 1990 Jul;84(4):263–268. doi: 10.1016/s0954-6111(08)80050-9. [DOI] [PubMed] [Google Scholar]
  8. Fabbri L. M., Boschetto P., Zocca E., Milani G., Pivirotto F., Plebani M., Burlina A., Licata B., Mapp C. E. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis. 1987 Jul;136(1):36–42. doi: 10.1164/ajrccm/136.1.36. [DOI] [PubMed] [Google Scholar]
  9. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  10. Holtzman M. J., Fabbri L. M., O'Byrne P. M., Gold B. D., Aizawa H., Walters E. H., Alpert S. E., Nadel J. A. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis. 1983 Jun;127(6):686–690. doi: 10.1164/arrd.1983.127.6.686. [DOI] [PubMed] [Google Scholar]
  11. Hutson P. A., Church M. K., Clay T. P., Miller P., Holgate S. T. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am Rev Respir Dis. 1988 Mar;137(3):548–557. doi: 10.1164/ajrccm/137.3.548. [DOI] [PubMed] [Google Scholar]
  12. Kim C. J., Kane G. C., Zangrilli J. G., Cho S. K., Koh Y. Y., Peters S. P. Eosinophils recruited to the lung by segmental antigen challenge show a reduced chemotactic response to leukotriene B4. Prostaglandins. 1994 May;47(5):393–403. doi: 10.1016/0090-6980(94)90056-6. [DOI] [PubMed] [Google Scholar]
  13. Lam S., LeRiche J., Phillips D., Chan-Yeung M. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma. J Allergy Clin Immunol. 1987 Jul;80(1):44–50. doi: 10.1016/s0091-6749(87)80189-6. [DOI] [PubMed] [Google Scholar]
  14. Lewis R. A., Austen K. F., Soberman R. J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990 Sep 6;323(10):645–655. doi: 10.1056/NEJM199009063231006. [DOI] [PubMed] [Google Scholar]
  15. Marder P., Sawyer J. S., Froelich L. L., Mann L. L., Spaethe S. M. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist. Biochem Pharmacol. 1995 May 26;49(11):1683–1690. doi: 10.1016/0006-2952(95)00078-e. [DOI] [PubMed] [Google Scholar]
  16. Marsh W. R., Irvin C. G., Murphy K. R., Behrens B. L., Larsen G. L. Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis. 1985 Jun;131(6):875–879. doi: 10.1164/arrd.1985.131.6.875. [DOI] [PubMed] [Google Scholar]
  17. Martin T. R., Pistorese B. P., Chi E. Y., Goodman R. B., Matthay M. A. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest. 1989 Nov;84(5):1609–1619. doi: 10.1172/JCI114338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Metzger W. J., Zavala D., Richerson H. B., Moseley P., Iwamota P., Monick M., Sjoerdsma K., Hunninghake G. W. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis. 1987 Feb;135(2):433–440. doi: 10.1164/arrd.1987.135.2.433. [DOI] [PubMed] [Google Scholar]
  19. O'Byrne P. M., Leikauf G. D., Aizawa H., Bethel R. A., Ueki I. F., Holtzman M. J., Nadel J. A. Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol (1985) 1985 Dec;59(6):1941–1946. doi: 10.1152/jappl.1985.59.6.1941. [DOI] [PubMed] [Google Scholar]
  20. Pavord I. D., Wong C. S., Williams J., Tattersfield A. E. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis. 1993 Jul;148(1):87–90. doi: 10.1164/ajrccm/148.1.87. [DOI] [PubMed] [Google Scholar]
  21. Richards I. M., Griffin R. L., Oostveen J. A., Morris J., Wishka D. G., Dunn C. J. Effect of the selective leukotriene B4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Am Rev Respir Dis. 1989 Dec;140(6):1712–1716. doi: 10.1164/ajrccm/140.6.1712. [DOI] [PubMed] [Google Scholar]
  22. Seltzer J., Bigby B. G., Stulbarg M., Holtzman M. J., Nadel J. A., Ueki I. F., Leikauf G. D., Goetzl E. J., Boushey H. A. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol (1985) 1986 Apr;60(4):1321–1326. doi: 10.1152/jappl.1986.60.4.1321. [DOI] [PubMed] [Google Scholar]
  23. Smith H. R., Larsen G. L., Cherniack R. M., Wenzel S. E., Voelkel N. F., Westcott J. Y., Bethel R. A. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol. 1992 Jun;89(6):1076–1084. doi: 10.1016/0091-6749(92)90291-9. [DOI] [PubMed] [Google Scholar]
  24. Sur S., Crotty T. B., Kephart G. M., Hyma B. A., Colby T. V., Reed C. E., Hunt L. W., Gleich G. J. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993 Sep;148(3):713–719. doi: 10.1164/ajrccm/148.3.713. [DOI] [PubMed] [Google Scholar]
  25. Virchow J. C., Jr, Walker C., Hafner D., Kortsik C., Werner P., Matthys H., Kroegel C. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med. 1995 Apr;151(4):960–968. doi: 10.1164/ajrccm/151.4.960. [DOI] [PubMed] [Google Scholar]
  26. Wardlaw A. J., Hay H., Cromwell O., Collins J. V., Kay A. B. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol. 1989 Jul;84(1):19–26. doi: 10.1016/0091-6749(89)90173-5. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES